<DOC>
	<DOCNO>NCT00806299</DOCNO>
	<brief_summary>A 10-day study determine grapefruit juice effect loperamide ( Imodium ) affect body body affect loperamide .</brief_summary>
	<brief_title>Loperamide Grapefruit Juice Interaction PK Trial</brief_title>
	<detailed_description>An open-label , randomize , single-dose , fixed-sequence crossover drug interaction study loperamide HCl grapefruit juice . About 33 healthy subject , equal number men woman , 18 59 year age , enrol 10 day trial . Subjects divide three cohort 11 subject . Each cohort receive red , white pink grapefruit juice . Subjects take 4 mg loperamide Day 1 . They ingest 8 ounce grapefruit juice 4 mg loperamide Day 3 . They ingest 8 ounce grapefruit juice morning evening Days 5 , 6 7 . On Day 8 , subject ingest 8 ounce juice 4 mg loperamide . Blood sample collect predose ( 0 ) 0.5 , 1 , 1.5 , 32 , 3 , 4 , 5 , 6 , 7 , 10 , 14 , 24 , 30 , 36 46 hour dose Day 1 , Day 3 Day 8 . Pupillometry assessment perform pre-dose ( 0 ) 2 , 4 , 6 , 8 , 12 hour dose Day 1 , Day 3 Day 8 . Subjects collect urine 8 PM 6 AM prior dosing Day 1 , Day 3 Day 8 .</detailed_description>
	<mesh_term>Loperamide</mesh_term>
	<mesh_term>Antidiarrheals</mesh_term>
	<criteria>Healthy male and/or female subject age 18 59 year , inclusive No clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , clinical laboratory test . Subjects Body Mass Index ( BMI ) approximately 18 30 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . Are normotensive sit blood pressure range 90 140 mm Hg systolic 50 90 mm Hg diastolic . Have heart rate 50100 beat per minute ( bpm ) . Have negative urine drug screen screen checkin research unit . If female childbearing potential , negative pregnancy test screen admission clinical research unit . Able sign date inform consent document , indicate subject ( legally acceptable representative ) inform pertinent aspect study . Received thorough explanation mandatory pharmacogenomic research component study sign separate pharmacogenomic inform consent document . Willingness ability comply schedule visit , treatment plan , laboratory test , study procedure . Extensive restriction type food drink allow Medical history precludes inclusion trial per protocol History allergy and/or sensitivity loperamide HCl History alcohol consumption precludes inclusion trial per protocol Positive screen test HIV , Hepatitis B Hepatitis C Treatment investigational drug within 30 day precede first dose study medication Females pregnant , nursing , unwilling unable use acceptable method nonhormonal contraception outline protocol Use prescription nonprescription drug , vitamin dietary supplement within 7 day 5 halflives prior first dose Donated lose blood blood product within 3 month first dose intention donate blood blood product within one month last dose History sensitivity heparin heparininduced thrombocytopenia Unwillingness inability comply Lifestyle Guidelines list protocol Relationship person involve directly conduct study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>October 2011</verification_date>
</DOC>